VANGUARD GROUP INC

Holdings History for Trevi Therapeutics, Inc. - Common Stock, $0.001 par value per share (TRVI)

Symbol
TRVI on Nasdaq
Investment type
Equity / Common Stock, $0.001 par value per share
Latest Disclosed Shares Owned
6,434,655 shares
Security Ownership %
5%
Shares, Excluding Options vs Price
Value, Excluding Options

The Vanguard Group ownership in Trevi Therapeutics, Inc. Common Stock, $0.001 par value per share (TRVI)

30 Jan 2026 - The Vanguard Group has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 6,434,655 shares of Trevi Therapeutics, Inc. Common Stock, $0.001 par value per share (TRVI). This represents 5% ownership of the company. This is the first filing by VANGUARD GROUP INC disclosing ownership of Trevi Therapeutics, Inc. Common Stock, $0.001 par value per share (TRVI).
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.